In our series, the risk of death was 90% higher for patients with any amount of residual disease but it only showed a trend toward statistical significance.
← all excerpts
En-bloc rectosigmoid and mesorectum resection as part of pelvic cytoreductive surgery in advanced ovarian cancer
1
—
—